Discours de Frédéric Fougerat au Marathon de la presse en RD Congo

Un #politique qui ne maîtrise pas sa #communication va subir celle des autres. En politique, laisser l’autre définir vos intentions, votre discours, votre #image, revient à lui offrir une victoire avant même l’échéance électorale.

#ComPol #MAP2025 🇨🇩
Marathon de la #presse

Rebecca Faila et Frédéric Fougerat, ensemble au 11e Marathon de la presse à Lubumbashi (RD Congo).

Le #leadership au féminin dans le Haut-Katanga se nomme Rebecca Faila. #Journaliste congolaise à l’initiative depuis 11 ans du Marathon de la #presse à Lubumbashi 🇨🇩 pour promouvoir la #ResponsabilitéDesMédias.

#MAP2025 - Crédit photos : Enoch Sangala.

Image de Frederic Fougerat, en interview dans les rues de Lubumbashi (Haut-Katanga / RDC)

Changer le narratif de l’#Afrique, c’est contribuer à changer son destin.
Journalistes et communicateurs africains : emparez-vous du sujet #EqualEarth, pour promouvoir une plus juste représentation de l’Afrique, sur le papier et dans l’imaginaire collectif mondial.

#MAP2025 🇨🇩

Listening in on cancer: AI tools may predict cancer’s next move, treatment responses, and muscle wasting At MAP 2025, artificial intelligence tools showed promise in outsmarting cancer by predicting tumour spread, treatment responses, and muscle wasting.

At #MAP2025, AI tools showed potential to forecast:
🔹 Muscle wasting in glioma
🔹 Which CUP treatments will work
🔹 When breast cancer turns invasive
Read on: medicalnewsinsider.substack.com/p/listening-...
#CancerResearch #AIinMedicine

👉 #MAP2025 sessions with speaker permission are now available online!
🔬 Registered delegates & ESMO members can watch on demand via #OncologyPRO and discover the latest progress in precision medicine.

🔗 buff.ly/PlTMpnQ

MAP2025: Epigenomic Signatures to Overcome Challenges in Oncology - ESMO - OncoDaily MAP2025: Epigenomic Signatures to Overcome Challenges in Oncology - ESMO / cancer, ESMO, ESMO Daily Reporter, MAP2025, OncoDaily, Oncology, Ovarian Cancer

ESMO - MAP2025: Epigenomic Signatures to Overcome Challenges in Oncology

@myesmo.bsky.social

oncodaily.com/voices/map20...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #MAP2025 #ESMO

Integrating multiomic spatial profiling and ctDNA for a deeper understanding of cancer complexity Diverse approaches are investigated in oncology that also include the use of artificial intelligence

#MAP2025: Umberto Malapelle describes how new technologies – #multiomic spatial profiling, #ctDNA analysis and #AI – can be integrated for a deeper understanding of cancer complexity.

Read more in the #ESMODailyReporter.

🔗 buff.ly/b26Mre7

Immune interception represents an exciting opportunity to stop cancer in its tracks Data from two studies suggest a good rationale for targeting T-cell dysfunction with precision immunotherapy to intercept pre-cancerous lesions

#MAP2025: Two studies highlight T-cell dysfunction in pre-cancerous lesions, supporting targeted immune interception as a novel #immunotherapy approach.

Read more in the #ESMODailyReporter #TranslationalResearch

🔗 buff.ly/BKFC2yU

Epigenetic analyses provide valuable insights into early cachexia detection in #glioma and #OvarianCancer evolution after #NeoadjuvantChemotherapy as presented at #MAP2025.

Read more in the #ESMODailyReporter:
🔗 buff.ly/QBmPzJl

🙌 MAP 2025 is happening now in Paris! 147 abstracts, 32 speakers & 14 sessions decoding cancer & enabling precision oncology. Explore AI diagnostics, cancer evolution, and new metabolic & epigenetic targets. #MAP2025

🔗 buff.ly/SXxdAYD

📣 The #MAP2025 abstracts are now online! Get a first look at the groundbreaking research in cancer prevention, AI, immunology & more before the congress in Paris, 15–16 Sept.

🔗 buff.ly/lbumSs1

👉 John Haanen emphasises that MAP 2025 sparks discussions and collaborations that drive precision oncology forward. Join the congress to learn, connect, and shape the future of cancer research. Be there. Be in Paris, 15-16 September 2025. #MAP2025

🔗 buff.ly/S374YAF

👉 The future of precision oncology is in Paris, 15–16 September.
⏰ Late registration for MAP 2025 ends 27 August at 23:59 CEST. AI, tumour evolution, and metabolic targets are on the agenda. Register now and save! #MAP2025

🔗 buff.ly/iDbdW73

📣 Prof. Haanen, Dr. Martínez-Jiménez & Prof. Swanton—Scientific Committee members—highlight #MAP2025 as a vital forum for collaboration in precision oncology. Join them in Paris, 15–16 Sept.
⏰ Register by tomorrow, and save!

🔗 buff.ly/SL9nwIt

👉 Just a few days left to submit your abstract for the Molecular Analysis for Precision Oncology Congress 2025 – deadline: 10 June, 21:00 CEST. Paris will host pioneers in molecular oncology, exploring cancer prevention, AI, immunotherapies, metabolism & more. #MAP2025

🔗 buff.ly/xEjbytH

👉 #MAP2025 Scientific Co-Chairs, Mariam Jamal-Hanjani, Lisa Derosa, and Joaquin Mateo share how collaboration fuels discovery.
⏰ submit your abstract by 10 June and join them and international peers from 15 to 16 September in Paris.

🔗 buff.ly/f9l4Rmp

📣 Register now for #MAP2025 and save! From 15-16 September in Paris, top experts in oncology and precision medicine will discuss AI in cancer care, immunotherapy, metabolism, and more.

👉 Don't miss out!

🔗 buff.ly/k2u6BNm